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RGK (Rad, Rem, Rem2, Gem/Kir) proteins are a four-member sub-
family of the Ras superfamily of monomeric G-proteins. Rad was ﬁrst
discovered as a protein over-expressed in the skeletal muscle of type
1645T. Yang, H.M. Colecraft / Biochimica et Biophysica Acta 1828 (2013) 1644–1654II diabetic humans [1]; Gem as a mitogen-induced gene in human T
cells [2]; Rem was originally cloned using a degenerate PCR strategy
based on similarity to Rad and Gem [3]; and Rem2 was cloned from
a rat brain cDNA library [4]. Functionally, individual RGKs have been
linked to diverse functions in different cell types and tissues including
(but not limited to): promotion of cell shape remodeling via regula-
tion of cytoskeletal dynamics (Gem) [5–9]; induction of apoptosis in
cardiac myocytes (Rad) [10]; regulation of synapse development
and dendritic morphology (Rem2) [11,12]; control of neuronal prolif-
eration and apoptosis during embryogenesis, and survival of human
embryonic stem cells (Rem2) [13,14].
All RGK proteins powerfully inhibit high-voltage-activated Ca2+
(CaV1/CaV2) channels [15–17]. In this review, we discuss the experi-
mental evidence that underlies current understanding of the mecha-
nisms and structural determinants underlying RGK regulation of CaV1/
CaV2 channels, its potential physiological role, and the state of efforts
to exploit this channel regulation for practical applications.
2. Basic structure–function of RGK proteins
Similar to other Ras superfamily proteins, RGKs contain a guanine
nucleotide binding domain (G-domain) [18–23]. In comparison to Ras,
RGK proteins have relatively large N- and C-termini extensions, and
non-conservative substitutions in the G-domain of residues critical for
GTP binding and hydrolysis [1–4] (Fig. 1). Within the RGK family, the
N-termini extensions have variable lengths and display low sequence
conservation. The functional signiﬁcance of the N-terminus extensions
in RGKs is unknown. The C-terminus extensions consist of a distal con-
served region (~40 residues) separated from the G-domain by a rela-
tively short (12–22 residues) variable linker sequence. The C-termini
of RGK proteins lack the CAAX (C = cysteine, A = aliphatic, X = any
amino acid) prenylation motif that is common to many Ras superfamily
proteins, and directs their anchoring to membranes [18]. Nevertheless,
RGKs target the plasma membrane using basic and hydrophobic resi-
dues in their C-terminus extensions [24,25]. The membrane-targeting
region in the C-termini of RGK proteins overlaps with a calmodulin
(CaM) binding domain (CBD) that mediates RGK interactions with
Ca2+–CaM [26–29] (Fig. 1A). 14-3-3 proteins bind as dimers to all four
RGKs, and this requires phosphorylation of two distinct serines in the
N- and C-termini extensions, respectively [6,26–28,30] (Fig. 1A). The
functional signiﬁcance of CaM and 14-3-3 binding to RGKs is unknown,
though it has been suggested that these interactions may regulate the
subcellular localization or stability of RGK proteins [6,27,28].
The G-domains of all RGKs have been functionally demonstrated to
be bona ﬁde guanine nucleotide binding proteins, although there may
be quantitative differences within the family [1–4,22,23]. For example,
Rad displays a higher afﬁnity (Kd≈100 nM) for guanine nucleotides
compared to Gem (Kd≈1–20 μM) [23]. Moreover, Gem displays a 5- to
10-fold higher afﬁnity for GDP vs GTP, whereas Rad displays no such
preference [23]. Crystal structures of RGK proteins conﬁrm that their
G-domains adopt a fold comprised of a six-stranded β-sheet surrounded
by ﬁve α-helices [20–22], similar to that found in other Ras superfamily
members [18,19] (Fig. 1B). In Ras superfamily proteins, ﬁve loops within
the G-domain (G1–G5) are highly conserved and form the guanine
nucleotide-binding site (Fig. 1). The G1-box (or P-loop) with consensus
sequence GXXXXGKS/T is conserved in RGKs, and similar to Ras, engages
in interactions that co-ordinate the α/β phosphates and Mg2+ [20–22].
Similarly, G4 (NKXD) and G5 (ETSA) motifs are conserved in RGKs and
participate in recognition of the guanine base. In Ras, G2 (XTX) and G3
(DXAG) motifs reside within regions referred to as Switch I and Switch
II, respectively. In Ras-GDP, Switch I and Switch II are disordered,
suggesting a high ﬂexibility of these regions. The Thr35 and Gly60 resi-
dues in Ras G2 and G3, respectively, act as sensors for the γ phosphate
of GTP. Hence, in Ras, GTP binding leads to a conformational change in
which switches I and II are stabilized [31]. Since RGKs do not have the
equivalent of Thr35 in switch I and show non-conservative substitutionsin G3 (DXWE instead of DXAG), it has long been suggested that theymay
not display the canonical GTP-regulated switch mechanism evident in
most Ras superfamily G-proteins [31]. Indeed, crystal structures of Rad
and Rem2 bound to a non-hydrolyzable GTP analog showed little struc-
tural changes from the GDP-bound forms, with no evidence of a GTP-
mediated stabilization of switches I and II [23]. A caveat that must be
mentioned is that all RGK protein crystal structures to date are of trun-
cated proteins in which the N- and C-termini extensions have been re-
moved (Fig. 1B). In some other G-proteins such as Ran and Arf, the
canonical switch mechanism is modiﬁed by additional conformation
changes in C- and N-termini extensions, respectively [31]. To this point,
a crystal structure of GDP-bound Gem that includes the initial part of
the C-terminus extension has been reported [22]. In this structure, the
proximal C-terminus extension forms a helix that contacts with an
interswitch region between the β2 and β3 strands of the G-domain, as
well as the α5 helix. Moreover, in functional assays, the presence of the
N- and C-termini extensions in Gem increases its GTPase activity by
20-fold [22].
The rate of intrinsic GTP hydrolysis has been measured for Rad
[23,32] and Gem [22,23]. Puriﬁed Rad has a low rate of intrinsic GTPase
activity which can be dramatically increased by cytosolic fractions de-
rived from different tissues [32]. Sub-fractionation of liver cytosol led
to the identiﬁcation of nucleoside diphosphate kinase (nm23 or NDPK)
as a GTPase activating protein (GAP) for Rad and Gem (but not Rem)
[33]. In an unusual twist, nm23 also acted as a functional guanine nucle-
otide exchange factor (GEF) for Gem due to its diphosphate kinase cata-
lyzing the transfer of phosphate from ATP to a bound GDP in Gem [33].
To date, nm23 is the only known GAP (and GEF) for any RGK protein.
3. Basic structure–function of CaV channels
Ca2+ inﬂux through voltage-dependent Ca2+ (CaV) channels plays a
critical role in various biological functions includingmuscle contraction,
synaptic transmission, hormone secretion, and gene expression [34,35].
CaV channels are divided into two main families based on their thresh-
old for activation: low-voltage-activated (LVA) Ca2+ channels and
high-voltage-activated (HVA) Ca2+ channels. There are three types of
LVA Ca2+ channels (T-type: CaV3.1–3.3) [36], and seven types of HVA
Ca2+ channels (L-type: CaV1.1−1.4; P/Q-type: CaV2.1; N-type: CaV2.2;
R-type: CaV2.3) [34,37].
HVA CaV channels are hetero-multimeric proteins comprised of pore-
forming α1 subunits and auxiliary β, α2δ, and sometimes γ subunits. So
far, seven genes encoding HVA α1 subunits (CaV1.1 [α1S]; CaV1.2 [α1C];
CaV1.3 [α1D]; CaV1.4 [α1F]; CaV2.1 [α1A]; CaV2.2 [α1B]; CaV2.3 [α1E])
[37], four genes encoding CaVβ (CaVβ1–4), and four genes encoding α2δ
(α2δ1–4) have been identiﬁed [34]. Pore-forming α1 subunits are all
comprised of four homologous domains (I−IV) each with six transmem-
brane segments (S1−S6). CaVβs are required for efﬁcient targeting of α1
subunits to the plasma membrane [38–42], enhancing channel open
probability (Po) [41], normalizing the voltage-dependence of channel ac-
tivation [43–46], and modulating inactivation [43,47–50]. CaVβs bind
with high afﬁnity to a conserved 18-residue sequence (the α interaction
domain, or AID) located in the loop connecting domains I and II (I–II loop)
of α1 subunits [51–53].
4. RGK inhibition of voltage-dependent calcium channels
4.1. Discovery and basic properties
The separate ﬁelds of RGK proteins and CaV channels intersected
when a yeast two hybrid screen of insulin-secretingMIN6 cells identiﬁed
Gem/Kir as a CaVβ3-binding protein [15]. Co-expression of recombinant
CaV1.3 or CaV1.2 channels with Gem in Xenopus oocytes resulted in a
complete and constitutive inhibition of both channel types [15]. Subse-
quently, it was found that the ability to inhibit CaV1.2 channels applied
to all RGK proteins [16,54]. Since these seminal studies, RGK proteins
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H-Ras (PDB ID: 5P21) and GNP-bound Rem2 G-domain (PDB ID: 3Q85).
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voltage-activated channels tested including, CaV1.1 [55], CaV1.2
[17,26,28,54,56–60], CaV1.3 [15], CaV2.1 [15,61,62], and CaV2.2
[15,56,63]. By contrast, low-voltage-activated T-type (CaV3.1–CaV3.3)
channels are unaffected by RGK proteins [16,63]. RGK inhibition of CaV1
and CaV2 channels takes place in all cell types studied to date, including
heterologous expression systems (e.g. HEK cells, Xenopus oocytes), cell
lines containing endogenous CaV channels (e.g. PC12 cells, MIN6 cells),
and primary cells (heart, skeletal muscle and neurons).4.2. RGKs use multiple mechanisms to inhibit CaV channels
The question of how RGKs inhibit CaV1 and CaV2 channels has been
intensely studied by several groups. The whole-cell calcium current
(ICa) is related to microscopic channel properties by the relation: ICa=
N×FA× i×Po, where N is the total number of channels in the surface
membrane, FA is the fraction of activatable channels, i is the unitary cur-
rent amplitude, and Po is the single-channel open probability. In princi-
ple, RGKs could inhibit ICa by reducing any one of the four parameters or
1647T. Yang, H.M. Colecraft / Biochimica et Biophysica Acta 1828 (2013) 1644–1654a combination of them. To address whether RGKs reduce N, Beguin and
colleagues used a CaV1.2 pore-formingα1C subunit harboring a hemag-
glutinin (HA) epitope tag in an extracellular loop. Combining immuno-
ﬂuorescence and confocal microscopy, they found that all four RGKs
prevent surface expression of HA-tagged CaV1.2 channels reconstituted
in either PC12 or HEK 293 cells [15,26,27]. By contrast, using a surface
biotinylation/Western blot detection approach, Finlin et al. found that
Rem2 inhibited ICa in mouse insulinoma MIN6 cells without reducing
the number of endogenous CaV1.2 channels at themembrane [54]. Sim-
ilarly, Ikeda and colleagues found that Rem2 inhibits CaV2.2 channels
stably expressed in tsA201 cells without decreasing the channel surface
density as determined by radio-labeled ω-conotoxin GVIA binding as-
says [63]. These two latter reports suggested that Rem2 inhibited
CaV1.2 and CaV2.2 channels directly at the cell surface, although the
exact mechanisms were not investigated.
By combining the optical detection of surface epitope-tagged α1C
subunits with quantum dot and high throughput ﬂow cytometry mea-
surements, our group discovered that Rem partially decreases (by 60%)
the surface density of recombinant CaV1.2 channels reconstituted in
HEK 293 cells [57]. This decrease was completely prevented by co-
expressing the dominant negative dynamin, suggesting that Rem in-
creased the rate of dynamin-dependent CaV1.2 endocytosis, rather than
interferedwith forward trafﬁcking of the channel [57] (Fig. 2,mechanism
I). Interestingly, even when Rem-induced decrease in the channel sur-
face density was completely reversed with dominant negative dynamin,C C C C O
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block the activity of surface channels. We distinguished two separate
mechanisms Rem used to block CaV1.2 channels at the cell surface.
First, Rem could decrease ICa by diminishing channel Po without accom-
panying reductions in voltage sensor movement (Fig. 2, mechanism II).
Targeting the Rem G-domain to the membrane either by the Rem
C-terminus or a generic membrane targeting module is sufﬁcient to re-
constitute mechanism II [57]. Second, we discovered that Rem reduced
the maximal gating charge (Qmax) of CaV1.2 channels in a manner that
was not accounted for by a decrease in N. This result suggested that
Rem partially immobilizes CaV1.2 channel voltage sensors (Fig. 2,mech-
anism III). On the assumption that all four voltage sensors are required to
move for the channel to open, the decreased Qmax suggests that Rem re-
duces the fraction of activatable (FA) CaV1.2 channels on the cell surface.
Overall, this study established thatwithin the same experimental system
Remutilized at least three separablemechanisms to inhibit recombinant
CaV1.2 channels [57,64].
Several groups have reported that over-expressing distinct RGKs in
cardiac myocytes or skeletal myotubes dramatically decreases endoge-
nous ICa,L [55,58–60]. In three of these studies the impact of RGKs on
Qmax was also measured. Murata et al. [60] found that over-expressing
Gem in adult guinea pig ventricular myocytes profoundly inhibited
CaV1.2 channel Qmax (70% reduction). By contrast, over-expressing
Rem in guinea pig ventricular myocytes [59] or skeletal myotubes [55]
yielded smaller reductions in CaV1.2 (33% reduction) and CaV1.1 (44%C C C C O
C C C C O
I
II
III
vated
+
+
+
+
+
+
+
+
I
II III
IV
+
+
+
+
+
+
+
+ II III
NT
+
+
+
+
+
+
+
+
II III
NT
Ca2+
Ca2+
Rem
rents fromHEK 293 cells expressing CaV1.2α1C+β2a. Right, representativeα1C+β2a channel
ucing channel surface density via enhanced dynamin-dependent endocytosis (mechanism I);
partially immobilizing channel voltage sensors as reported by a decrease in maximal gating
uire GTP to be bound to the Remnucleotide binding domain (represented as a red hexagon).
ing to Rem (represented as a green hexagon).
1648 T. Yang, H.M. Colecraft / Biochimica et Biophysica Acta 1828 (2013) 1644–1654reduction) Qmax, respectively. RGK-mediated decrease in CaV1.1/CaV1.2
channel Qmax could result from a decrease in the surface density of
channels or an ability of RGKs to partially immobilize channel voltage
sensors. The impact of RGKs on ICa,L in cardiac myocytes has often
been interpreted to reﬂect a decrease in the surface density of CaV1.2
channels [58,60,65]. However, we discovered that acute treatment of
control and Rem-over-expressing myocytes with the CaV1.2 channel
agonist, BAY K 8644, eliminated the inhibitory effect of Rem and
resulted in ICa,L of comparable amplitude between the two condi-
tions [59]. This result not only demonstrated that Rem-inhibited ICa,L
can be rescued pharmacologically, but also indicated that the majority
of CaV1.2 channels must be present at the cell surface in cardiac
myocytes over-expressing Rem. This contrasts with the ﬁnding that
Rem signiﬁcantly reduces the surface density of recombinant CaV1.2
channels reconstituted in PC12 or HEK 293 cells [17,57], suggesting
that although RGKs can inhibit CaV1.2 channels using multiple distinct
mechanisms, only particular subsets of these may be available and
used in different cellular contexts.
5. Structural determinants on RGKs important for ICa inhibition
5.1. Role of the RGK C-terminus
Much work has focused on deﬁning the important structural ele-
ments on RGKs that mediate their potent inhibition of CaV1/CaV2 chan-
nels. Deleting the N-terminus extension from different RGKs does not
abolish their ability to inhibit ICa [61–63], suggesting that this non-
conserved feature is not critical for this effect. By contrast, several inves-
tigators havedemonstrated that deleting thedistal C-terminus of individ-
ual RGKs generates truncated versions (e.g. Rem265, Rad276, Gem264) that
do not block ICa [16,56,57,59,62,63,66]. Hence, the distal C-terminus of
RGKs is clearly critical for themechanismof CaV channel block. Neverthe-
less, the precise manner in which the C-termini of RGKs participate in ICa
inhibition is not completely clear, though the available evidence suggests
that multiple mechanisms may be in play. Ambiguities arise in part due
to the overlapping roles of RGK C-termini — as membrane-targeting
modules, as CaM binding sites, and as bearers of nuclear localization sig-
nals (NLS) (Fig. 1A).
5.2. Is RGK C-terminus sufﬁcient to inhibit ICa?
Several investigators have sought to determine whether the
C-terminus of different RGK proteins is sufﬁcient to inhibit ICa with
mixed results. Ikeda and colleagues found that over-expressing the
C-terminus of Rem2 in SCG neurons did not block endogenous CaV2.2
channels, whereas full-length Rem2 strongly inhibited ICa [63]. Similar-
ly, expression of the Rem distal C-terminus (ﬁnal 32 residues) did not
inhibit recombinant CaV1.2 channels in tsA201 cells [66]. By contrast,
Leyris et al. found that the ﬁnal 75 residues of Gem, which include the
entire C-terminus extension, were sufﬁcient to fully inhibit recombi-
nant CaV2.1 channels reconstituted in Xenopus oocytes [67]. Recently,
a 12-amino acid peptide containing residues K265–K276 in the Gem
C-terminus was shown to be sufﬁcient to acutely inhibit CaV2.1 chan-
nels expressed in Xenopus oocytes, albeit at high concentrations [62].
In this study, the Gem K265−K276 peptide was directly applied to
CaV2.1 in the inside-out patch conﬁguration, explicitly demonstrating
that the inhibitory effect was achieved at the level of surface channels.
Remarkably, a scrambled Gem K265–K276 peptide, which contained
the same amino acid residues as the original but in different positions,
also effectively inhibited CaV2.1 in inside-out patches [62], suggesting
that the amino acid content of this region rather than its sequence
was important for channel inhibition. The region corresponding to
Gem residues K265–K276 is quite well conserved among RGK proteins
(Fig. 1A). Therefore, the inability of Rem2 and Rem C-termini to inhibit
CaV2.2 channels in SCG neurons [63] and CaV1.2 in tsA201 cells [66], re-
spectively, may indicate that the sufﬁciency of this region to block ICa, asobserved with Gem K265−K276 inhibition of CaV2.1 channels [62,67]
may not be a general property. Alternatively, one possible explanation
for the discrepancies could be that the effective concentration of the
expressed C-terminal fragment was different in these studies — higher
in oocyte studies and lower in cell lines. Further work is needed to clar-
ify this issue, as well as the mechanism K265–K276 peptide uses to de-
crease CaV2.1.
5.3. Role of RGK membrane targeting
In many cell types, RGK proteins autonomously target to the inner
leaﬂet of the plasma membrane via their C-termini interacting with
membrane phosphatidylinositol lipids [24,25,56,63,66]. Deleting the dis-
tal C-terminus of RGKs eliminates both their ability to inhibit ICa and
their membrane targeting [56,63,66]. The potential importance of RGK
membrane targeting in themechanism of ICa inhibition has been investi-
gated by several groups. Replacing the C-termini of either Rem2 [63] or
Rem [66] with the tail of K-Ras4B which consists of a polybasic region
and a CAAX prenylation motif, restored both membrane targeting and
inhibition of CaV2.2 and CaV1.2 channels, respectively. For Rem2, the po-
larity of the membrane targeting domain appeared to be important, as
attaching the ﬁrst 10 residues from Gαi1, which contains myristoylation
and palmitoylation motifs, to the N-terminus of truncated Rem2
(Rem2ΔC) restored membrane targeting but not inhibition of CaV2.2
channels [63]. By contrast, attaching a palmitoylated peptide to the N-
terminus of truncated Rem (Rem265) restored bothmembrane targeting
and inhibition of CaV2.2 channels stably expressed in tsA201 cells [56].
Overall, the available data suggest that oneway the RGK C-terminus par-
ticipates in ICa inhibition depends on its ability to target the RGK
G-domain to the plasma membrane. We exploited this feature to create
a small-molecule-inducible CaV1/CaV2 channel inhibitor by fusing the C1
domain from protein kinase Cγ to either the N- or C-terminus of YFP-
Rem265 [17,56,57]. The resulting constructs, C1PKCγ-YFP-Rem265 or
YFP-Rem265-C1PKCγ, are cytosolic when expressed in HEK 293 cells, but
are rapidly recruited to the membrane upon exposure to phorbol-
12,13-dibutyrate (PdBu) [56,57]. Inhibition of CaV1.2 and CaV2.2 chan-
nels occurs concomitantly with the dynamic translocation of C1PKCγ-
YFP-Rem265 or YFP-Rem265-C1PKCγ to the plasma membrane [17,56,57].
These molecules were termed genetically encoded molecules for
inducibly inactivating CaV channels (GEMIICCs) [56]. GEMIICCs acutely
inhibited ICa without affectingQmax, suggesting they lowered the current
solely by decreasing channel Po [56,57] (Fig. 2, mechanism II). Beyond
providing insights into the mechanism by which membrane targeting
of RGKs results in ICa inhibition, GEMIICCs provide a proof-of-concept
that new functionalities (in this case inducible inhibition) can be
engineered into RGKs.
5.4. Role of CaM binding and nuclear localization of RGKs
In addition to mediating targeting to the membrane, the C-terminus
of RGKs binds CaM and possesses nuclear localization signals (Fig. 1A). A
useful mutationwidely used in the ﬁeld converts a hydrophobic residue
in the RGK C-terminus (corresponding to GemW269 RemL271 RadL281
Rem2L317) to glycine (Fig. 1A). The effects of this mutation are complex
since it diminishes CaM binding [26–28], prevents membrane targeting
[57], and dramatically increases nuclear localization of RGKs [26–28,57].
Hence, the functional consequences of this mutation in RGKs need to be
interpreted carefully. GemW269G consistently shows a diminished ability
to inhibit ICa compared to wild-type Gem. This effect has been demon-
strated for GemW269G inhibition of CaV1.2 channels in PC12 cells
[15,28] and cardiac myocytes [60], and CaV2.2 channels in SCG neurons
[6]. Similarly, RadL281G displayed a diminished ability to inhibit CaV1.2
channels in PC12 cells, whereas RemL271G retained full inhibitory activity
in the same system [26]. The precise reason for the functional differences
between GemW269G/RadL281G and RemL271G is not clear. Because these
mutations markedly increase the nuclear localization of the respective
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RadL281G and RemL271G could represent amechanism to regulate surface
CaV1.2 channels [26]. An ambiguity with these experiments is that
though the mutant RGKs are enriched in the nucleus, a signiﬁcant por-
tion remains in the cytosol. Hence, in the case of RemL271G it was unclear
whether inhibition of CaV1.2 channels was achieved via the nuclear or
cytosolic pools of themutant protein.We examined this question by ex-
amining the effect of RemL271G on CaV1.2 channels reconstituted in HEK
293 cells [57]. YFP-RemL271G in HEK cells was present in both the nucle-
us and cytosol and caused a partial inhibition of ICa,L when compared to
wild type Rem. Attaching a nuclear localization signal (NLS) to
YFP-RemL271G localized it exclusively to the nucleus. Interestingly,
NLS–YFP-RemL271G was completely inert with respect to ICa,L inhibition.
Conversely, attaching a nuclear export signal (NES) to YFP-RemL271G
targeted it exclusively to the cytosol, andNES–YFP-RemL271G completely
blocked ICa,L, explicitly demonstrating that the cytosolic pool is the active
component for channel inhibition. These results support three conse-
quential conclusions. First, the ineffectiveness of GemW269G and
RadL281G to inhibit ICa may be because their nuclear localization reduces
their active concentration in the cytosol. This interpretation is consistent
with the ﬁnding that RGK inhibition of ICa is dose-dependent [68]. Sec-
ond, that CaM binding is not necessary for RGK inhibition of ICa. Third,
that membrane targeting of RGKs is not an absolute requirement for
ICa inhibition, since the non-membrane-targeted NES–YFP-RemL271G is
an effective blocker of CaV1.2 channels.
5.5. Role of nucleotide binding and hydrolysis in RGK inhibition of ICa
A canonical feature of Ras superfamilyG-proteins is that they function
as guanine nucleotide-regulatedmolecular switches, cycling between in-
active GDP-bound and active GTP-bound conformations [18]. There is
tremendous ambiguity as towhether andhow this basic deﬁning proper-
ty plays a role in RGK regulation of CaV1/CaV2 channels. All RGKs have
been demonstrated to be bona ﬁde guanine nucleotide binding proteins
though there may be quantitative differences among them with respect
to relative afﬁnities for GDP and GTP, and the intrinsic rate of GTP hydro-
lysis. Comparing the crystal structures of GTP- and GDP-bound Rad and
Rem2 suggest that RGKs do not undergo the classical switch mechanism
observed in Ras, which involves a GTP-mediated stabilization of other-
wise disordered Switch I and Switch II regions [23,31]. An important ap-
proach used to investigate the potential role of GTP binding and
hydrolysis of RGKs is to introduce point mutations that decrease their af-
ﬁnities for guanine nucleotides. In Ras, a S17Nmutation locks the protein
in a GDP-bound state [69]. RasS17N has a dominant negative effect on Ras
signaling in cells because it has a higher afﬁnity for, and sequesters,
Ras-GEFs [69]. The residue corresponding to Ras S17 is conserved in all
RGKs (RadS105, GemS89, RemT94, Rem2S129) (Fig. 1A). Similar to the
S17N mutation in Ras, GTP binding is abolished in RadS105N and
GemS89N, although the afﬁnity to GDP is also reduced [23,32].
Over a series of papers, Beguin and colleagues demonstrated using
pull-down assays that RadS105N, GemS89N, RemT94N, and Rem2S129N
displayed decreased binding to CaVβ subunits compared to their
wild-type counterparts [26–28]. This was interpreted as indicating that
GTP binding was necessary for RGKs to bind CaVβs. However, the impact
of thesemutations on the ability of the distinct RGKs to inhibit ICawas not
evaluated in these studies. A different conclusion regarding the role of nu-
cleotide binding in RGKs was reached in a study where the Rem2/CaVβ2a
interaction was unaffected when Rem2 was loaded with either GDP or
GTP [24].
A number of studies have focused on evaluating the functional impact
of the nucleotide binding state of RGKs on their ability to inhibit ICa, with
mixed results. Chen et al. found that Rem2S129N down-regulated ICa to
the same extent aswild type Rem2 in sympathetic neurons [63]. Howev-
er, the same group also found that GemS89N lost the ability to inhibit ICa in
sympathetic neurons [6]. This discrepancy hints at a fundamental differ-
ence between these two RGKs with respect to the role of nucleotidebinding in ICa inhibition in neurons. RadS105N has been reported to have
no effect on recombinant CaV1.2 channels reconstituted in HEK 293
cells, but to exert a dominant negative effect in cardiac myocytes, in-
creasing endogenous ICa,L [70]. By contrast, we found that RemT94N po-
tently inhibited CaV1.2 channels in HEK 293 cells, but with an
interesting difference fromwild-type Rem. Whereas wild-type Rem sig-
niﬁcantly decreased gating currents, RemT94N blocked ICa without
impacting Qmax [57]. This result suggested that the ability of Rem to in-
hibit voltage sensor movement is selectively dependent on GTP binding
(Fig. 2, mechanism III). Surprisingly, over-expressing RemT94N in heart
cells had no impact on endogenous ICa,L, in contrast to wild-type Rem
which markedly decreased ICa,L [59]. Given that RemT94N does inhibit
CaV1.2 channels in HEK 293 cells, this result suggests the existence of a
cardiac speciﬁc mechanism that inactivates the ability of GDP-bound
Rem to inhibit ICa,L in the heart. A caveat of all the functional studies de-
scribed here is that they rely onmutations predicted to lock RGKproteins
in a GDP-bound state. It is possible that these mutations may also have
some unanticipated effects that could confound the interpretation of
the results. To circumvent this problem, Chen et al. attempted to reverse
Rem2 inhibition of ICa in sympathetic neurons by dialyzing in GDP-β-S
via the patch pipette [63]. They observed no reversal of ICa inhibition
over 20 min of GDP-β-S dialysis, suggesting that GTP binding may not
be necessary for Rem2 inhibition of ICa in sympathetic neurons.
6. Structural determinants on CaV1/CaV2 channels important for
RGK inhibition
6.1. Role of auxiliary β subunits in RGK regulation of CaV channels
All RGK proteins bind CaVβ subunits [15–17,26,56,71–73]. The afﬁn-
ity of RGK/CaVβ association is about an order of magnitude lower than
the interaction of CaVβ with the AID present in the I–II loop of CaV1/
CaV2 pore-forming α1 subunits [56]. The relatively low afﬁnity of the
RGK/CaVβ interaction may explain the lack of a high resolution crystal
structure for this complex. Beguin et al. conducted an extensive muta-
genesis screen of CaVβs and RGKs to identifymutations that interrupted
their mutual interaction without disrupting their global tertiary struc-
tures [72]. Mutations on CaVβ that eliminated interaction with RGKs
clustered at a hotspot region that was distinct from theα-binding pock-
et that binds the AID [74–76] (Fig. 3A). Based on the results from this
mutagenesis screening and the known structures of RGKs and CaVβs,
the authors generated a homology model in which Gem was docked
to the identiﬁed hotspot on CaVβ (Fig. 3B).
It was initially suggested that RGKs bind to CaVβs and prevent their
interaction with α1 subunits, thereby compromising their chaperone
function and severely limiting channel trafﬁcking to the membrane
[15,26,77]. However, subsequentwork has shown that RGKs do not dis-
rupt theα1–β interaction, and there is consensus that RGK inhibition of
ICa involves a ternary α1/β/RGK complex [24,54,56,57,63]. Within this
ternary complex framework, there are two possible ways in which
CaVβ could play a role in the RGK inhibition of ICa. In the ﬁrst scenario,
a direct RGK/CaVβ interaction is not necessary for ICa inhibition. Howev-
er, CaVβ could play a role by promoting a permissive conformation of
the channel complex that is necessary for functional interaction with
RGKs. Alternatively, a direct RGK/CaVβ interaction could be obligatory
for the mechanism of RGK inhibition of ICa. Evidence has been provided
for both scenarios, and there are indications that there may be speciﬁc-
ity for different RGK/CaV channel combinations as discussed below. An
important tool that made these advances possible was the discovery
of speciﬁc mutations in CaVβs that selectively eliminated binding to
RGKs without compromising functional regulation of CaV α1 subunit
trafﬁcking and gating [17,61,72] (Fig. 3C).
Jian Yang's group used a mutated CaVβ that no longer binds RGKs to
demonstrate that direct interaction with CaVβ was not necessary for
Gem to acutely inhibit CaV2.1 channels in Xenopus oocytes [61]. Never-
theless, they further showed that β binding to α1A was necessary for
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aβwithweakened afﬁnity forα1A, which could be readilywashed off in
inside-out patches. With the βwashed off, Gem no longer inhibited the
channel, though it could still bindα1A. On the basis of these results, they
proposed amodel where the presence of β exposes an inhibitory site on
the channel complex that is then engaged by Gem to block CaV2.1
[53,61]. The location of this putative inhibitory site on the CaV2.1 chan-
nel complex that binds Gem is currently unknown.
We investigated whether the RGK/β interaction has any role in the
mechanism of ICa inhibition, or merely represents an unrelated epiphe-
nomenon, by examining Rem inhibition of CaV1.2 channels in HEK 293
cells [17]. We found that CaV1.2 channels containing a β2a mutant that
selectively loses binding to RGK proteins (Fig. 3C), are less potently
inhibited (74% inhibition) by Rem than channels containing wild-type
β2a (96% inhibition), suggesting the prevalence of bothβ-binding depen-
dent and independent modes of inhibition [17] (Fig. 3, E–H). We further
found that twomechanistic signatures of Rem inhibition of CaV1.2 chan-
nels (decreased N and Po), but not a third (reduced Qmax), depend on
Rembinding to CaVβ. Surprisingly,wediscovered a functional dichotomy
among the RGKs—while Rem and Rad used both β-binding-dependent
and independent mechanisms to inhibit CaV1.2, Gem and Rem2 solely
utilized aβ-binding-dependentmethod to do so [17] (Fig. 4). These ﬁnd-
ingsmay explainwhy CaV1.2 channels expressed in the absence ofβ sub-
units are partially blocked by Rem in HEK 293 cells [78], but minimally
affected by Gem or Rem2 in Xenopus oocytes [15,68,79]. Finally, we
found that Rem inhibition of CaV2.2 channels was completely dependent
on the Rem/CaVβ interaction, in contrast with CaV1.2 [17]. Therefore, the
mechanisms of RGK inhibition of CaV1/CaV2 channels are customized at
the levels of both the RGK and the channel type. Overall, these data sug-
gest a dualistic view for RGK inhibition of CaV channels. First, all RGKs caninhibit all CaV1/CaV2 channels via mechanisms that depend on direct
RGK/CaVβ interactions. Because CaVβs are necessary for the formation
of all functionally mature CaV channels, this could explain the promiscu-
ity of RGKs in blocking all CaV1/CaV2 channel types. Second, distinct
RGKs may initiate β-binding-independent channel inhibition through
selective interaction with speciﬁc CaV1/CaV2 channel pore-forming α1
subunits [17].
6.2. Direct interactions of RGKs with CaV α1 subunits
A logical explanation for the observation that speciﬁc RGKs can in-
hibit CaV2.1 and CaV1.2 channels without binding to β subunits is that
particular RGKs directly interact with individual CaV1/CaV2α1 subunits.
Consistent with this idea, Gem co-immunoprecipitates with CaV2.1 α1A
in the absence of CaVβ [61]. Nevertheless, the exact Gem binding sites
on α1A that underlie channel inhibition are unknown. By exchanging
corresponding fragments between P/Q- (α1A) and T-type channels
(CaV3.1 α1G), Fan et al. showed that the region comprised of the S1–
S3 transmembrane segments of domain II conferred Gem sensitivity
[61]. However, since Gem is an intracellular protein, it is most likely
that IIS1–IIS3 may be involved in the transduction of the effect, rather
than being a binding site for Gem [61,79].
There have also been efforts to identify direct RGK binding sites on
CaV1.2 α1C subunit. Pang et al. [80] reported that Rem (as well as Rad
and Rem2) directly binds to proximal and distal regions in the
C-terminus of α1C. The proximal α1C C-terminus contains structural ele-
ments, including aCaMbinding domain and anEFhandmotif, that are es-
sential for Ca2+-dependent regulation (inactivation and facilitation) of
CaV1.2 [81–86]. Ca2+–CaM was found to block the Rem/α1C C-terminus
interaction in vitro. This interplay was not due to Ca2+–CaM interaction
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Figure reproduced from [17].
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Ca2+–CaM for α1C C-terminus [80]. Furthermore, co-overexpression of
CaM was found to partially relieve Rem inhibition of CaV1.2 channels in
tsA201 cells. The authors concluded that direct binding to the proximal
α1C C-terminus is important for Rem-mediated regulation of CDI and
ICa,L blockade in CaV1.2 [80]. Results from our group support a different
conclusion. Based on the idea that the putative Rem binding site
was most likely localized within an intracellular region of the channel,
we conducted an unbiased screen for potential Rem interaction sites
onα1C (N- andC-termini, I–II, II–III, and III–IV loops) using three indepen-
dent approaches (ﬂuorescence resonance energy transfer, co-localization
analyses, and co-immunoprecipitation assays) [17]. We found that Rem
interacts solely with the α1C N-terminus in the region immediately
upstream of transmembrane segment I in domain I (IS1). Moreover,
over-expressing α1C N-terminus completely rescued Rem-mediated
β-binding-independent inhibition of CaV1.2 channels, suggesting that
Rem/α1C N-terminus interaction underlies this mode of regulation.
Neither Rem2 nor Gem bound α1C N-terminus, providing an explana-
tion for why they exhibit only a β-binding-dependent mechanism of
CaV1.2 inhibition. Although the distal N-terminus shows homology
among distinct CaV1/CaV2 α1-subunits (60% identical residues or con-
servative substitutions), Rem does not bind CaV2.2 α1B N-terminus
[17]. This explains why Rem inhibits CaV2.2 channels solely through a
β-binding-dependent mechanism.7. Crosstalk of RGK and protein kinase signaling on CaV1.2 channels
In the heart, up-regulation of CaV1.2 channels by protein kinase A
(PKA) is an important physiological modulation that contributes to
sympathetic regulation of the heartbeat, a critical component of the
ﬂight-or-ﬁghtmechanism [87,88]. Two reports have documented an in-
teresting cross talk between RGKs and PKA signaling at the level of
CaV1.2 channels in the heart. Speciﬁcally, in primary cardiac myocytes
over-expressing either Rad [58] or Rem [59], the remaining ICa,L was
completely insensitive to PKAmodulation. By contrast, the CaV1.2 chan-
nel agonist BAY K 8644 robustly and acutely rescued ICa,L in myocytes
over-expressing Rem [59]. The mechanism by which RGKs prevent
PKA-mediated modulation of CaV1.2 channels in the heart is unknown.
A recent study found that α1-adrenergic receptor stimulation could
attenuate Rem inhibition of CaV1.2 channels in both HEK 293 cells and
cardiac myocytes [65]. The mechanism was found to involve activation
of protein kinase D1 (PKD1) and subsequent phosphorylation of Rem at
residue Ser18. The authors propose that this leads to sequestration of
Rem by 14-3-3 proteins and permits CaV1.2 channels trapped intracel-
lularly to trafﬁc to the cell surface [65].
8. Practical applications of RGK inhibition of CaV channels
Inhibition of CaV1/CaV2 channels is an important or potential therapy
for many cardiovascular and neurological diseases including: hyperten-
sion, cardiac arrhythmias, neuropathic pain, Alzheimer's disease, and
Parkinson's disease [89–92]. Under certain circumstances, intracellular
genetically encoded CaV channel inhibitors may have advantages over
traditional small-molecule blockers [93]. For example, localized expres-
sion of RGKs may permit a more restricted inhibition of CaV channels,
permitting a targeted therapeutic result while minimizing unwanted
off-target effects [93]. In a proof of concept demonstration of this princi-
ple, focal gene delivery of Gem to the atrioventricular (AV) node slowed
AV nodal conduction and reduced the heart rate in a porcine atrial ﬁbril-
lation model [60].
The potential practical applications of RGKsmay bewidely expanded
if new functionalities such as inducibility and selectivity could be
engineered into them. To this end,we have developed engineered deriv-
atives of Remwhich are inert but can be acutely activated by small mol-
ecules to inhibit ICa [56]. Recently, a caveolae-targeted Rem has been
developed that selectively inhibits caveolae-localized Cav1.2 channels
in heart cells [94]. This molecule selectively inhibits hypertrophic Ca2+
signaling pathways in cardiac myocytes without impairing contractility.
9. Physiological signiﬁcance of RGK inhibition of ICa
In contrast to the steady progress in evaluating the mechanisms by
which RGKs inhibit CaV1/CaV2 channels, the physiological role of this
channel regulation remains somewhat mysterious. Many different ex-
citable cell types co-express RGKs and speciﬁc CaV1/CaV2 channel
isoforms. For example, Rad and Rem are expressed in cardiac and skel-
etal muscles [3,16,95], Rem2 is expressed in neurons and pancreatic
β-cells [4,11,54,96], and Gem is present in mitogen-activated T cells
and pancreatic β cells [2,15,97]. This leads to the expectation that RGK
inhibition of CaV channels plays a physiological role in these cells. How-
ever, this is difﬁcult to prove for two main reasons.
First, RGKs have been shown to interact with many other signaling
molecules besides CaV channel subunits. Therefore, it is difﬁcult to spe-
ciﬁcally assign any (patho)physiological consequences that arise from
knockout of individual RGKs to their effect on CaV channels. Knockout
mice for Rad [95], Gem [97], and Rem [98] have been generated. Rad
knockout mice display an increased susceptibility to transverse aortic
constriction (TAC) induced hypertrophy, and down-regulation of Rad
is correlated with the development of heart failure in humans [95]. ICa,L
has not beenmeasured in thesemice so it is unknownwhether this con-
tributes to the observed phenotype. However, deciphering the potential
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acts with CaMKII [29,95] and Rho kinase [99,100], two signaling mole-
cules well known to be involved in the development of pathological
cardiac hypertrophy [101,102]. Gem knockout mice displayed glucose
intolerance, impaired insulin secretion in response to high glucose, and
abnormal Ca2+ handling in pancreatic β-cells [97]. ICa in β-cells was
not measured, precluding any inferences about a possible role of CaV
channel dysregulation in these abnormalities. Rem knockout mice ex-
hibit a moderately increased ICa in cardiac myocytes, without showing
any overt cardiac phenotype [98]. Interpretation of the results may be
confounded by compensatory mechanisms as well as the fact that
other RGKs present in the heart may provide a redundant pathway for
ICa inhibition. To date, themost direct evidence that an RGKmaymediate
constitutive inhibition of ICa in an excitable cell comes from a study
which demonstrated that knockdown of Rad with shRNA resulted in
an increase in ICa,L in cultured cardiac myocytes [58]. Similarly RNAi
knockdown of Rem2 in neurons demonstrated a role in synaptic devel-
opment and dendritic morphology [11,12], and reduced the frequency
of miniature excitatory postsynaptic currents [96]. However, the Rem2
knockdown in hippocampal neurons had no impact on ICa, suggesting
that other effectors underlie the observed functional effects.
A second reason for the difﬁculty in evaluating the physiological role
of RGK inhibition of CaV channels in different systems has to dowith the
likely constitutive, background nature of this regulation. Development
of approaches that can selectively and acutely relieve RGK inhibition
of CaV channels would appear to be necessary for progress in determin-
ing the physiological role of this form of CaV1/CaV2 channel regulation.
10. Conclusion
All RGKs powerfully and promiscuously inhibit all CaV1 and CaV2
channels. Surprisingly, this seemingly homogenous and simple phe-
nomenon is underlain by a rich variety of mechanisms and structural
determinants [57,68]. The mechanisms and structural determinants of
RGK inhibition of CaV channels appear to be customized based on the
RGK type, CaV1/CaV2 channel isoform, and cellular context. This may
have contributed to apparently contradictory reports in the ﬁeld. Fur-
ther work is needed to deﬁne the precise mechanisms that different
RGKs use to inhibit distinct CaV1/CaV2 channel isoforms in speciﬁc cell
types. Nailing down the physiological role and importance of RGK inhi-
bition of CaV channels has proven difﬁcult due to the constitutive nature
of this inhibition, the fact that RGKs functionally interact with other im-
portant signaling molecules, and the existence of compensatory mech-
anisms and redundant pathways in knockout mice. New tools that
permit acute relief of RGK inhibition of CaV channels are needed to
probe the physiological signiﬁcance of this phenomenon. Finally, RGKs
and engineered derivatives have potential utility as therapeutics and
useful molecular tools. Exploring these dimensions of the RGK/CaV
channel functional interaction is an exciting area for future research.
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